GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (FRA:SR3) » Definitions » Net Cash per Share

Staar Surgical Co (FRA:SR3) Net Cash per Share : €2.29 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Staar Surgical Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Staar Surgical Co's Net Cash per Share for the quarter that ended in Dec. 2024 was €2.29.

The historical rank and industry rank for Staar Surgical Co's Net Cash per Share or its related term are showing as below:

FRA:SR3' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 7.41   Med: 20.46   Max: 39.81
Current: 7.41

During the past 13 years, the highest Price-to-Net-Cash Ratio of Staar Surgical Co was 39.81. The lowest was 7.41. And the median was 20.46.

FRA:SR3's Price-to-Net-Cash is ranked better than
50.62% of 322 companies
in the Medical Devices & Instruments industry
Industry Median: 7.655 vs FRA:SR3: 7.41

Staar Surgical Co Net Cash per Share Historical Data

The historical data trend for Staar Surgical Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Net Cash per Share Chart

Staar Surgical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.63 2.09 2.52 2.22 2.29

Staar Surgical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.74 2.49 2.31 2.29

Competitive Comparison of Staar Surgical Co's Net Cash per Share

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Price-to-Net-Cash falls into.


;
;

Staar Surgical Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Staar Surgical Co's Net Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as

Net Cash per Share (A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(220.122-107.14-0)/49.294
=2.29

Staar Surgical Co's Net Cash per Share for the quarter that ended in Dec. 2024 is calculated as

Net Cash per Share (Q: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(220.122-107.14-0)/49.294
=2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Staar Surgical Co  (FRA:SR3) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Staar Surgical Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Staar Surgical Co Business Description

Traded in Other Exchanges
Address
25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Staar Surgical Co Headlines

No Headlines